Pharmaceutical giant Sun Pharmaceutical Industries is anticipated to report consistent revenue growth, albeit with subdued profitability in its results for the September 2025 quarter (Q2FY26), impacted by increased costs associated with its US
The Subject Expert Committee (SEC) which is under the Central Drugs Standard Control Organization (CDSCO) has given the green signal to AstraZeneca India Pharma Limited’s application of Sodium Zirconium Cyclosilicate
Continuing its growth journey after the major investment in Hyderabad, Eli Lilly and Company now plans to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park. The new site will increase...
Akums Drugs and Pharmaceuticals has made a major landmark by receiving a 20-year patent for its revolutionary 'tablet-in-tablet' technology aimed at treating Gastroesophageal Reflux Disease (GERD).
MedGenome, a leading global genomics-based diagnostics and research company, has made a majority investment in Gujarat-headquartered Green Cross Genetics Lab, strengthening its footprint in India’s growing diagnostics market...
Roche today reported positive Phase III results for Gazyva (obinutuzumab) in adults with systemic lupus erythematosus (SLE) receiving standard therapy. The ALLEGORY study met its main goal, showing more patients achieved a four-point improvement...
The World Health Organization (WHO) has published new guidelines for nations on how to mitigate the short-term and long-term consequences of abrupt and drastic cuts to external financing, which are interfering with the provision of critical health se
Cipla Ltd. had signed binding agreements to purchase the entire shareholding of Inzpera Healthscience Pvt. Ltd. for around Rs 110.65 crore.
Amgen has declared that new findings from its cardiovascular portfolio, which includes late-breaking results from the phase 3 VESALIUS-CV clinical trial of Repatha (evolocumab), will be showcased at the American Heart Association (AHA) Scientific
Takeda has completed its seven-year Phase 3 TIDES trial of QDENGA confirming that the vaccine provides lasting and reliable protection against dengue. The study, which also looked at the effects of a booster dose, showed that QDENGA maintains...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")